Neuromuscular HOMEepAGE
neuromuscular.wustl.edu
/
A–Z

Inflammatory Myopathy with Abundant Macrophages (IMAM)

Immune/AntibodyOMIM 123886
W
View full entry on WUSTL Neuromuscular
antibody/infmyop.htm#Inflammatory Myopathy with Abundant Macrophages (IMAM) 40

Overview

From WUSTL Neuromuscular

Clinical Onset Ages: Childhood to 78 years Progression: Days to Weeks Children Most commonly asymptomatic Skin Rash: May be similar to dermatomyositis Edema Muscle Weakness: Proximal; Mild to Marked Myalgias Systemic features (25%) Arthralgias Raynaud's Lung infiltrate Treatment Corticosteroids Other immunomodulation Course Remission in some: After immunomodulating treatment Death: Occasional; Multiple organ failure may occur Laboratory Serum CK: Normal or Mildly high Aldolase: May be high with normal CK Serum autoantibodies: No consistent pattern Muscle pathology Histiocyte (Macrophage) infla

OMIM Entries

OMIM #123886

External Resources

WUSTL Neuromuscular
Washington University Disease Center
OMIM
Online Mendelian Inheritance in Man
PubMed
Biomedical Literature
GeneReviews
NCBI Expert-Authored Reviews
Orphanet
Portal for Rare Diseases
NORD
National Organization for Rare Disorders

Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.